• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number CONTEGRA
Device Problems Calcified (1077); Gradient Increase (1270)
Patient Problems Calcium Deposits/Calcification (1758); High Blood Pressure/ Hypertension (1908); Pulmonary Valve Stenosis (2024)
Event Date 12/07/2016
Event Type  Injury  
Manufacturer Narrative
Citation: falchetti et al.Contegra 12 mm: how long can it last - world j pediatr congenit heart surg.E-published (b)(6) 2016 earliest date of publish used for event date.(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a (b)(6) year old female with a medical history of type 1 truncus arteriosus, large ventricular septal defect, right ventricular hypertrophy, and truncal valve regurgitation who underwent implant of a medtronic (b)(4) (serial number not provided) before 1 year of age.Postoperative pulmonary hypertension was reported at the time of surgery and the patient was discharged home.At the age of (b)(6) years, the patient presented with conduit stenosis and increased gradients as shown via transthoracic echocardiography.Mild shrinkage of the conduit and moderate peripheral calcification was revealed on computed tomography (ct).The patient underwent successful explant and replacement of the with another unspecified conduit.The recovery was uneventful and the patient was discharged home 16 days postoperative.Evaluation of the explanted conduit found fibrin spots in occasional nodules, peripheral calcifications, and moderate infiltration of multinucleated cells with the leaflets intact.No further patient adverse effects were reported.
 
Event Description
Additional information received from the physician/author provided: a statement that the conduit performed much longer than expected, and (b)(6).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALVE CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6244285
MDR Text Key64578831
Report Number2025587-2017-00079
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCONTEGRA
Device Catalogue NumberCONTEGRA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/15/2016
Initial Date FDA Received01/11/2017
Supplement Dates Manufacturer ReceivedNot provided
03/06/2017
Supplement Dates FDA Received03/09/2017
09/28/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age16 YR
Patient Weight3
-
-